# OnCo record nmtrc003 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nmtrc003/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nmtrc003", "NCT02395666" ;
  schema:name "NMTRC003/003B (DFMO maintenance)"@en ;
  schema:description "NMTRC003 was the single-arm study, compared against historical patients, that got eflornithine approved as maintenance; the design remains debated."@en ;
  schema:url <https://onco.cc/trials/nmtrc003/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02395666> ;
  onco:status "positive" ;
  onco:tag "lesson:external-control" ;
  onco:phase "2" ;
  schema:startDate "2015-03-05" ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/neuroblastoma-high-risk/> ;
  onco:drugs <https://onco.cc/drugs/eflornithine/> .